Sirita Lashawn Canty, LPN | |
1596 Rulane Dr, Lapeer, MI 48446-1364 | |
(313) 737-1500 | |
Not Available |
Full Name | Sirita Lashawn Canty |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 1596 Rulane Dr, Lapeer, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164990255 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 4703108891 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sirita Lashawn Canty, LPN 1596 Rulane Dr, Lapeer, MI 48446-1364 Ph: (313) 737-1500 | Sirita Lashawn Canty, LPN 1596 Rulane Dr, Lapeer, MI 48446-1364 Ph: (313) 737-1500 |
News Archive
Figures show that each year half a million kids age 5 and younger get into household medications and are poisoned. Though parents tend to believe that these tragic accidents will never happen to their kids, Dr. Randall Bond, a leading advocate for better prescription drug safety in the home, believes it can happen to anyone.
Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.
This week's issue of the Journal of the American Medical Association (Dec 16) features a report on a long-term, prospective study of elderly, dementia-free individuals led by researchers from Boston University School of Medicine and the Framingham Heart Study focusing on the association between the protein hormone Leptin and the risk of developing Alzheimer's disease (AD).
RTI Surgical, Inc., a global surgical implant company, will showcase research reinforcing the strength of its spine portfolio, notably the Fortilink IBF series featuring TETRAfuse 3D Technology, at the North American Spine Society's 33rd Annual Meeting in Los Angeles, September 26-29.
Researchers have reported a major advance in the creation of a successful HIV vaccine that is not produced by the host animal.
› Verified 9 days ago